5 September 2017 - The Biosafety Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
A phase II study evaluating the efficacy and the safety of first-line chemotherapy combined with TG4010 and nivolumab in patients with advanced non-squamous Non-Small-Cell Lung Cancer (NSCLC)